Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.

@article{Oh2009RadiocopperlabeledCA,
  title={Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.},
  author={Myungmi Oh and Takeshi Tanaka and Masato Kobayashi and Takako Yoshino Furukawa and Tetsuya Mori and Takashi Kudo and Shigeharu Fujieda and Yasuhisa Fujibayashi},
  journal={Nuclear medicine and biology},
  year={2009},
  volume={36 4},
  pages={
          419-26
        }
}
View on PubMed
kawai.w3.kanazawa-u.ac.jp
52 Citations
Highly Influential Citations
3
Background Citations
19
Methods Citations
5
Results Citations
4

Figures and Tables from this paper

52 Citations

Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.

(64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.

Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.

64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2

Data from colorectal cancer xenografts indicated that 64Cu-ATSM may not be a hypoxia marker in all tumor types, and data from FaDu and HT29 tumor models indicated that 63Cu-atSM but not 64CuCl2 reflected pO2 measurements, indicating that 64 Cu-AT SM is ahypoxia-specific marker in this tumor type.

62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET in Human Gliomas: Comparative Study with [18F]Fluorodeoxyglucose and L-Methyl-[11C]Methionine PET

62Cu-diacetyl-bis(N4-methylthiosemicarbazone) may be a practical radiotracer in the prediction of glioblastoma multiforme and may provide intratumoral hypoxic information useful in establishing targeted therapeutic strategies for patients with gliOBlastomaMultiforme.

Comparison of intratumoral FDG and Cu-ATSM distributions in cancer tissue originated spheroid (CTOS) xenografts, a tumor model retaining the original tumor properties.

Application of 62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET Imaging to Predict Highly Malignant Tumor Grades and Hypoxia-Inducible Factor-1α Expression in Patients with Glioma

It is demonstrated that 62 Cu-ATSM uptake is relatively high in grade IV gliomas and correlates with the MR imaging findings of necrosis, and the 62Cu-AT SM T/B ratio showed significant correlation with HIF-1α expression.

PET Imaging of Hypoxia-Inducible Factor-1-Active Tumor Cells with Pretargeted Oxygen-Dependent Degradable Streptavidin and a Novel 18F-Labeled Biotin Derivative

Pretargeting with POS and 18F-FBB is an effective approach for PET imaging of HIF-1-active areas in tumors.

Alteration of Cellular Reduction Potential Will Change 64Cu-ATSM Signal With or Without Hypoxia

It is demonstrated that Copper(II)-diacetyl-bis(4-methylthiosemicarbazonato) (Cu-ATSM) signal is dependent on cellular redox state, irrespective of hypoxia, which has implications for the use of 64Cu- ATSM as a predictive marker for redox therapies, though further in vivo work is needed.

Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?

...

References

SHOWING 1-10 OF 30 REFERENCES

Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models.

Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

Cu-ATSM exhibits selectivity for hypoxic tumor tissue both in vivo and in vitro and may provide a successful diagnostic modality for the detection of tumor ischemia.

Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent Cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells

In subcellular fractions of tumor cells, Cu-ATSM was reduced mainly in the microsome/cytosol fraction rather than in the mitochondria, completely different from that found in normal brain cells.

Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor mo

Evaluation of62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer

62 Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) (62Cu-ATSM) is a promising PET tracer for tumor imaging, which might bring new information for chemotherapeutic treatment and radiotherapy of hypoxic tumors.

Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer.

The negative correlation between blood flow and flow normalized 62Cu-ATSM uptake suggests an enhancement of retention of 62 Cu-AT SM by low flow, which might bring new information for chemotherapeutic treatment as well as radiotherapy of hypoxic tumors.

Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats.

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Systemic administration of hypoxia-selective (64)Cu-diacetyl-bis(N(4)-methylthiosemicarbazone (ATSM) has increased the survival time of tumor-bearing animals significantly with no acute toxicity and thus is a promising agent for radiotherapy.

Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.